DSS Announces Licensing of Impact BioMedical's Linebacker

ROCHESTER, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and...

Related Keywords

United States ,American ,Ted Karkus ,Frankd Heuszel ,Daryl Thompson ,Nasdaq ,Globe Newswire Dss Inc ,Impact Biomedical Inc ,Prophase Lab ,Securities Exchange ,Prophase Biopharma Inc ,Redchip Companies Inc ,Dss Inc ,Global Biolife Inc ,Prophase Labs Inc ,Global Biolife ,Impact Biomedical ,Prophase Biopharma ,Prophase Labs ,Chief Executive Officer ,Product Packaging ,Direct Marketing ,Commercial Lending ,Investment Management ,Alternative Trading ,Digital Transformation ,Secure Living ,Securities Act ,Securities Exchange Act ,Relations Contact ,